The challenging differential diagnosis of skin tumours with a rhabdoid phenotype: not all tumours with rhabdoid phenotype belong to the group of SMARCB1-deficient tumours

Histopathology. 2016 Mar;68(4):608-12. doi: 10.1111/his.12790. Epub 2015 Sep 17.

Authors

Jo Van Dorpe¹, Anne Hoorens¹, Nadine Van Roy², Franceska Dedeurwaerdere³, David Creytens¹

Affiliations

¹ Department of Pathology, Ghent University Hospital, Ghent, Belgium.
² Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
³ Department of Pathology, AZ Delta, Roeselare, Belgium.

PMID: 26216536
DOI: 10.1111/his.12790

No abstract available

Publication types

Case Reports

MeSH terms

Biomarkers, Tumor / analysis
Breast Neoplasms / pathology
Chromosomal Proteins, Non-Histone / genetics
DNA-Binding Proteins / genetics
Diagnosis, Differential
Female
Humans
Immunohistochemistry
Microscopy, Electron, Transmission
Middle Aged
Neoplasm Recurrence, Local / genetics
Neoplasm Recurrence, Local / pathology
Neoplasms, Second Primary / genetics
Neoplasms, Second Primary / pathology*
Phenotype
Rhabdoid Tumor / diagnosis*
Rhabdoid Tumor / genetics
SMARCB1 Protein
Scalp / pathology
Skin Neoplasms / diagnosis*
Skin Neoplasms / genetics
Transcription Factors / genetics

Substances

Biomarkers, Tumor
Chromosomal Proteins, Non-Histone
DNA-Binding Proteins
SMARCB1 Protein
SMARCB1 protein, human
Transcription Factors